Phase 1 Advanced Ovarian Cancer Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors

Advanced Solid TumorAdvanced Breast CancerAdvanced Ovarian Cancer

Bristol-Myers Squibb234 enrolled21 locationsNCT06997029

Recruiting

Phase 1

A Study of MOv18 IgE in Patients With Solid Tumours That Express Folate Receptor Alpha

Advanced Ovarian Cancer

Epsilogen Ltd45 enrolled7 locationsNCT06547840

Not Yet Recruiting

Phase 1

This trial is a phase 1, single-centre, open label, single-dose study of 89Zr-APOMAB using PET/CT imaging in a series of 18 participants who are known to have inoperable stage III or stage IV non-small cell lung cancer (NSCLC), or limited or extensive stage small cell lung cancer (SCLC), or FIGO stage IV grade 3 serous papillary Ovarian Cancer.

Advanced Lung CancerAdvanced Ovarian Cancer

Central Adelaide Local Health Network18 enrolled1 locationACTRN12620000622909